SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.

Jiang G, Tang J, Zhao H, Zhang K, Gao J, Yang B, Wang L, Yang H, Chen L, An R, Zhang H, Bu H, Tang J, Xu X, Ruan X, Xia B, Wang K, Wei L, Sheng X, Guo Z, Chen L, Wang W, Li J, Wang D, Zhan P, Guo Y, Wang Y, Dong Y, Zhu J

Open source

DOI: 10.1002/ajh.70481
Published: 2026 Aug 26
Container: American journal of hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70481,
  title = {SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.},
  author = {Jiang G and Tang J and Zhao H and Zhang K and Gao J and Yang B and Wang L and Yang H and Chen L and An R and Zhang H and Bu H and Tang J and Xu X and Ruan X and Xia B and Wang K and Wei L and Sheng X and Guo Z and Chen L and Wang W and Li J and Wang D and Zhan P and Guo Y and Wang Y and Dong Y and Zhu J},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70481},
  url = {https://doi.org/10.1002/ajh.70481}
}

RIS

TY  - JOUR
TI  - SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.
AU  - Jiang G
AU  - Tang J
AU  - Zhao H
AU  - Zhang K
AU  - Gao J
AU  - Yang B
AU  - Wang L
AU  - Yang H
AU  - Chen L
AU  - An R
AU  - Zhang H
AU  - Bu H
AU  - Tang J
AU  - Xu X
AU  - Ruan X
AU  - Xia B
AU  - Wang K
AU  - Wei L
AU  - Sheng X
AU  - Guo Z
AU  - Chen L
AU  - Wang W
AU  - Li J
AU  - Wang D
AU  - Zhan P
AU  - Guo Y
AU  - Wang Y
AU  - Dong Y
AU  - Zhu J
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70481
UR  - https://doi.org/10.1002/ajh.70481
ER  -

APA

G, J., J, T., H, Z., K, Z., J, G., B, Y., L, W., H, Y., L, C., R, A., H, Z., H, B., J, T., X, X., X, R., B, X., K, W., L, W., X, S., Z, G., L, C., W, W., J, L., D, W., P, Z., Y, G., Y, W., Y, D., & J, Z. (2026). SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.. American journal of hematology. https://doi.org/10.1002/ajh.70481

Source records

pubmed · retrieved 2026-09-26T21:39:33.779Z